| Income Statement | 2025-06-30 | 2025-03-31 | 2024-09-30 | |
|---|---|---|---|---|
| Net loss | -27,746 | -26,465 | -26,311 | |
| Net loss attributable to noncontrolling interests | -17 | -34 | -25 | |
| Net loss attributable to atai life sciences n.v. stockholders | -27,729 | -26,431 | -26,286 | |
| Earnings per share, basic | -0.14 | -0.15 | -0.16 | |
| Earnings per share, diluted | -0.14 | -0.15 | -0.16 | |
| Weighted average common shares outstanding attributable to atai life sciences n.v. stockholders - basic (denominator) | 196,563,699 | 176,271,176 | 160,621,817 | |
| Weighted average common shares outstanding attributable to atai life sciences n.v. stockholders - diluted | 196,563,699 | 176,271,176 | 160,621,817 | |
ATAI Life Sciences N.V. (ATAI)
ATAI Life Sciences N.V. (ATAI)